Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact firstname.lastname@example.org.
SOURCE Research and Markets
DUBLIN, Feb. 11, 2014 /PRNewswire/ --
Research and Markets
) has announced the addition of the
report to their offering.
The ability of patients to monitor their own serum levels is deemed to be a critical tool in reducing the pathological effects of poorly controlled disease factors. For conditions other than diabetes, the vast majority of monitoring has until recently been performed in physician offices or similar healthcare settings.
The convergence of new measurement technologies, patient demographics and managed care cost initiatives is driving patient monitoring for a number of conditions from caregiver facilities and into homes. In the process, patient self-monitoring for cholesterol, INR and hypertension have the potential to transition from a cottage industry into a significant market. The key enabler of this significant shift will be technological advances that will provide accurate readings in a format that consumers can understand, clearly indicating when a follow-up visit to a caregiver is needed. Systems that allow patients to share readings with physicians electronically have already been introduced. Ultimately, the success of this self-test market will rely on monitors that can provide accurate values for the various analytes that are associated with health risk, presenting them to the patient in the proper context.
Key Topics Covered:
Disease Management Market Dynamics
Patient Monitoring Overview
Key Factors in Patient Compliance
Shifting Patient Demographics
Industry Alignment and Competitive Landscape
Self-Monitoring Technology Strategies
Self-Collected / Mail-in Tests
Signal Processing Advances
Monitor Product Design & Patient Issues
Self-Monitoring Therapeutic Segments
Atherosclerosis/Heart Disease (Cholesterol)
Heart Valve Replacement/Thrombosis
Hypertension (Blood Pressure)
Self-Monitoring Product Segment Analysis
Noninvasive Glucose Monitors
Potential/Emerging Self-Monitoring Segments
Clinical Trial Issues
Regulations and Guidance
Patient Self-Monitoring - Company Profile
For more information visit http://www.researchandmarkets.com/research/kbggl2/patient
Media Contact: Laura Wood , +353-1-481-1716, email@example.com
©2012 PR Newswire. All Rights Reserved.